HIGHLIGHTS
- who: Laura Pu00e9rez-Fernu00e1ndez and collaborators from the University of Pisa, Italy have published the paper: Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study, in the Journal: (JOURNAL)
- what: The BRAFV600E mutation status was determined for research purposes in consecutive patients at each center and did not affect decisions on selection of treatments. The authors show that the PVE in this 3-tiered DRS system remains high. This study has some limitations. To conclude, in this nation-wide multicenter study the authors provide . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.